AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Postal Ballot Notice29-09-2022
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Postal Ballot NoticeAARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot NoticeAARTI DRUGS LTD. - 524348 - Re-Appointment Of Managing Director/ Outcome Of Board Meeting
based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors at its meeting held today approved the re-appointed of Shri Rashesh C. Gogri (DIN: 00066291) as the Managing Directors.AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants)AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for issuance of Letter of Confirmation in lieu of Duplicate Share CertificateAARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the Investor ConferenceAARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for issuance of Letter of Confirmation in lieu of Duplicate Share CertificateAARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, kindly note that the Company has issued the Letter of Confirmation in lieu of Duplicate Share CertificateAARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the Investor Conference